Plasma Cell Neoplasm — Trials

Plasma Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 992 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07479979	Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma	recruiting	Phase 1 / Phase 2	62	Natalie CallanderOTHER	1	Aug 31, 2026	clinicaltrials
NCT00602641	Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma	active not recruiting	Phase 3	306	National Cancer Institute (NCI)NIH	2	Aug 28, 2026	clinicaltrials